{"Q": 1, "answer": "no", "rationale": "The segment reports discussions but does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_10564", "batch_size": 200, "batch_pos": 128, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports factual information about discussions without using high-potency language.", "method": "llm_batch", "batch_id": "batch_2_18560", "batch_size": 200, "batch_pos": 100, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with significant scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_2808", "batch_size": 200, "batch_pos": 79, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_18348", "batch_size": 200, "batch_pos": 74, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports discussions but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_16280", "batch_size": 200, "batch_pos": 71, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser with scale contrast.", "method": "llm_batch", "batch_id": "batch_6_9812", "batch_size": 200, "batch_pos": 53, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "No bare negation found.", "method": "llm_batch", "batch_id": "batch_7_4596", "batch_size": 200, "batch_pos": 45, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Mentions company 'are in discussions with the U.S. government on advancing our pandemic flu candidate' which is a capability/action without explicit calming.", "method": "llm_batch", "batch_id": "batch_8_1968", "batch_size": 200, "batch_pos": 161, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
